79
Views
1
CrossRef citations to date
0
Altmetric
Review

New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center’s experience

, , , , , & show all
Pages 93-106 | Published online: 29 Aug 2012

References

  • HammarströmPWisemanRLPowersETKellyJWPrevention of transthyretin amyloid disease by changing protein misfolding energeticsScience2003299560771371612560553
  • KellyJWColonWLaiZTransthyretin quaternary and tertiary structural changes facilitate misassembly into amyloidAdv Protein Chem1997501611819338081
  • BensonMDKincaidJCThe molecular biology and clinical features of amyloid neuropathyMuscle Nerve200736441142317554795
  • ConnorsLHLimAProkaevaTRoskensVACostelloCETabulation of human transthyretin (TTR) variants, 2003Amyloid200310316018414640030
  • JacobsonDRPastoreRDYaghoubianRVariant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black AmericansN Engl J Med199733674664739017939
  • WestermarkPSlettenKJohanssonBCornwellGG3rdFibril in senile systemic amyloidosis is derived from normal transthyretinProc Natl Acad Sci U S A1990877284328452320592
  • UedaMAgeyamaNNakamuraSAged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human diseaseLab Invest201292347448422184092
  • CoelhoTSousaALourençoERamalheiraJA study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffectedJ Med Genet19943142932998071954
  • KoikeHTanakaFHashimotoRNatural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areasJ Neurol Neurosurg Psychiatry201283215215822228785
  • Planté-BordeneuveVLaluTMisrahiMGenotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathyNeurology19985137087149748014
  • HellmanUAlarconFLundgrenHESuhrOBBonaiti-PelliéCPlanté-BordeneuveVHeterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish populationAmyloid200815318118618925456
  • HörnstenRPennlertJWiklundULindqvistPJensenSMSuhrOBHeart complications in familial transthyretin amyloidosis: impact of age and genderAmyloid2010172636820462364
  • ArakiSKuriharaTTawaraSKuribayashiTFamilial amyloidotic polyneuropathy in JapaneseGlennerGGPinho e CostaPde FreitasAFAmyloid and AmyloidosisAmsterdamExcerpta Medica19806777
  • CoutinhoPda SilvaAMLimaJKBarbosaARForty years of experience with type I amyloid neuropathy: review of 483 casesGlennerGGPinho e CostaPde FreitasAFAmyloid and AmyloidosisAmsterdamExcerpta Medica19798898
  • SuhrODanielssonAHolmgrenGSteenLMalnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathyJ Intern Med199423554794858182405
  • TashimaKSuhrOBAndoYGastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met): comparison of Swedish and Japanese patientsAmyloid19996212412910439119
  • AdamsDSamuelDGoulon-GoeauCThe course and prognostic factors of familial amyloid polyneuropathy after liver transplantationBrain2000123Pt 71495150410869060
  • De CarvalhoMConceiçãoIBentesCLuísMLLong-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M)Amyloid20029212613312440485
  • DubreySWDavidoffRSkinnerMBergethonPLewisDFalkRHProgression of ventricular wall thickening after liver transplantation for familial amyloidosisTransplantation199764174809233704
  • García-HerolaAPrietoMPascualSProgression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variantLiver Transpl Surg19995324624810226117
  • GustafssonSIhseEHeneinMYWestermarkPLindqvistPSuhrOBAmyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosisTransplantation201293101017102322395298
  • HörnstenRWiklundUOlofssonBOJensenSMSuhrOBLiver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patientsTransplantation200478111211615257048
  • OlofssonBOBackmanCKarpKSuhrOBProgression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese typeTransplantation200273574575111907421
  • PomfretEALewisWDJenkinsRLEffect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathyTransplantation19986579189259565095
  • StangouAJHawkinsPNHeatonNDProgressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesisTransplantation19986622292339701270
  • SuhrOBHerleniusGFrimanSEriczonBGLiver transplantation for hereditary transthyretin amyloidosisLiver Transpl20006326327610827225
  • GraziGLCesconMSalviFCombined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of viewLiver Transpl20039998699212942463
  • PilatoEDell’AmoreABottaLArpesellaGCombined heart and liver transplantation for familial amyloidotic neuropathyEur J Cardiothorac Surg200732118018217449267
  • CoelhoTMaiaLFMartins da SilvaATafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trialNeurologyIn press2012
  • DyckPJMeltonLJ3rdO’BrienPCServiceFJApproaches to improve epidemiological studies of diabetic neuropathy: insights from the Rochester Diabetic Neuropathy StudyDiabetes199746Suppl 2S5S89285491
  • BergströmJGustavssonAHellmanUAmyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphologyJ Pathol2005206222423215810051
  • KoikeHAndoYUedaMDistinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathyJ Neurol Sci20092871–217818419709674
  • IhseEYboASuhrOLindqvistPBackmanCWestermarkPAmyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosisJ Pathol2008216225326118729067
  • IhseESuhrOBHellmanUWestermarkPVariation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosisJ Mol Med (Berl)201189217118021107516
  • IhseEStangouAJHeatonNDProportion between wild-type and mutant protein in truncated compared to full-length ATTR: an analysis on transplanted transthyretin T60A amyloidosis patientsBiochem Biophys Res Commun2009379484685019118530
  • BlevinsGMacaulayRHarderSOculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69HisNeurology200360101625163012771253
  • PetersenRBGorenHCohenMTransthyretin amyloidosis: a new mutation associated with dementiaAnn Neurol19974133073139066351
  • SchweitzerKEhmannDGarciaRAlportEOculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69HisCan J Ophthalmol200944331731919491989
  • UemichiTUittiRJKoeppenAHDonatJRBensonMDOculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64Arch Neurol19995691152115510488818
  • IkedaSNakazatoMAndoYSobueGFamilial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneityNeurology20025871001100711940682
  • SousaAAnderssonRDruggeUHolmgrenGSandgrenOFamilial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalenceHum Hered19934352882948406517
  • ZarosCGeninEHellmanUOn the origin of the transthyretin Val30Met familial amyloid polyneuropathyAnn Hum Genet200872Pt 447848418460047
  • KoikeHMisuKIkedaSType I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset formArch Neurol200259111771177612433265
  • KoikeHMisuKSugiuraMPathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathyNeurology200463112913815249622
  • OlssonMHellmanUPlanté-BordeneuveVJonassonJLångKSuhrOBMitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patientsClin Genet200975216316819018796
  • BonaïtiBOlssonMHellmanUSuhrOBonaïti-PelliéCPlanté-BordeneuveVTTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?Eur J Hum Genet201018894895220234390
  • GibbonsCHIlligensBMCentiJFreemanRQDIRT: quantitative direct and indirect test of sudomotor functionNeurology200870242299230418541883
  • NovakPQuantitative autonomic testingJ Vis Exp2011532502
  • YangNCLeeMJChaoCCClinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97SerNeurology201075653253820697105
  • AndoYYamashitaTTanakaYRole of nitric oxide in the peripheral vessels of patients with familial amyloidotic polyneuropathy (FAP) type IJ Auton Nerv Syst199450179857844317
  • DyckPJZimmermanIGillenDAJohnsonDKarnesJLO’BrienPCCool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptorsNeurology1993438150015088351002
  • FruhstorferHLindblomUSchmidtWCMethod for quantitative estimation of thermal thresholds in patientsJ Neurol Neurosurg Psychiatry1976391110711075188989
  • GruenerGDyckPJQuantitative sensory testing: methodology, applications, and future directionsJ Clin Neurophysiol19941165685837860720
  • JamalGAHansenSWeirAIBallantyneJPAn improved automated method for the measurement of thermal thresholds: 1. Normal subjectsJ Neurol Neurosurg Psychiatry19854843543603998741
  • LinYHHsiehSCChaoCCChangYCHsiehSTInfluence of aging on thermal and vibratory thresholds of quantitative sensory testingJ Peripher Nerv Syst200510326928116221286
  • RolkeRBaronRMaierCQuantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference valuesPain2006123323124316697110
  • SelimMMWendelschafer-CrabbGHodgesJSVariation in quantitative sensory testing and epidermal nerve fiber density in repeated measurementsPain2010151357558120851518
  • YarnitskyDQuantitative sensory testingMuscle Nerve19972021982049040659
  • YarnitskyDSprecherEThermal testing: normative data and repeatability for various test algorithmsJ Neurol Sci1994125139457964887
  • KandelERSchwartzJHJessellTMPrinciples of Neural Science4th edNew YorkMcGraw-Hill/Appleton and Lange2000
  • SchmidtRFAltnerHFundamentals of Sensory PhysiologyNew York (NY)Springer-Verlag1978
  • BecserNSandTZwartJAReliability of cephalic thermal thresholds in healthy subjectsCephalalgia19981885745829827251
  • ClausDHilzMJHummerINeundörferBMethods of measurement of thermal thresholdsActa Neurol Scand19877642882963687380
  • HeldestadVLinderJSellersjöLNordhEReproducibility and influence of test modality order on thermal perception and thermal pain thresholds in quantitative sensory testingClin Neurophysiol2010121111878188520478739
  • HilzMJGloriusSBerićAThermal perception thresholds: influence of determination paradigm and reference temperatureJ Neurol Sci199512921351407608727
  • LevyDAbrahamRReidGA comparison of two methods for measuring thermal thresholds in diabetic neuropathyJ Neurol Neurosurg Psychiatry1989529107210772795077
  • LowensteinLJesseKKentonKComparison of perception threshold testing and thermal-vibratory testingMuscle Nerve200837451451718067137
  • MeierPMBerdeCBDiCanzioJZurakowskiDSethnaNFQuantitative assessment of cutaneous thermal and vibration sensation and thermal pain detection thresholds in healthy children and adolescentsMuscle Nerve200124101339134511562914
  • VerdugoROchoaJLQuantitative somatosensory thermotest: a key method for functional evaluation of small calibre afferent channelsBrain1992115Pt 38939131628207
  • HeldestadVNordhEQuantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathyMuscle Nerve200735218919517094098
  • HsuWBettegowdaCJalloGIIntramedullary spinal cord tumor surgery: can we do it without intraoperative neurophysiological monitoring?Childs Nerv Syst201026224124519902217
  • KortelainenPPuranenJKoivistoELähdeSSymptoms and signs of sciatica and their relation to the localization of the lumbar disc herniationSpine (Phila Pa 1976)198510188923983706
  • TravellJGSimonsDGMyofascial Pain and DysfunctionPhiladelphia (PA)Lippincott Williams & Wilkins1992
  • VallboABHagbarthKEWallinBGMicroneurography: how the technique developed and its role in the investigation of the sympathetic nervous systemJ Appl Physiol20049641262126915016790
  • EslerMClinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responsesPharmacol Toxicol19937352432538115306
  • LowPAClinical Autonomic Disorders: Evaluation and ManagementBoston (MA)Little Brown and Co1993
  • LowPACaskeyPETuckRRFealeyRDDyckPJQuantitative sudomotor axon reflex test in normal and neuropathic subjectsAnn Neurol19831455735806316835
  • WangAKFealeyRDGehrkingTLLowPAPatterns of neuropathy and autonomic failure in patients with amyloidosisMayo Clin Proc200883111226123018990321
  • DelahayeNRouzetFSardaLImpact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathyMedicine (Baltimore)200685422923816862048
  • HörnstenRSuhrOBJensenSMWiklundUOutcome of heart rate variability and ventricular late potentials after liver transplantation for familial amyloidotic polyneuropathyAmyloid200815318719518925457
  • KinoshitaOHongoMSaikawaYHeart rate variability in patients with familial amyloid polyneuropathyPacing Clin Electrophysiol19972012 Pt 1294929539455756
  • WiklundUHörnstenRKarlssonMSuhrOBJensenSMAbnormal heart rate variability and subtle atrial arrhythmia in patients with familial amyloidotic polyneuropathyAnn Noninvasive Electrocardiol200813324925618713325
  • WiklundUHörnstenROlofssonBOSuhrOBCardiac autonomic function does not improve after liver transplantation for familial amyloidotic polyneuropathyAuton Neurosci20101561–212413020478749
  • AbeMAndoYHigashiKKanoTNon-neurogenic periodic fluctuations in heart rate and vasomotion appearing in familial amyloid polyneuropathy (FAP) type I (Met30)J Auton Nerv Syst1996601–271758884698
  • HörnstenRSuhrOBOlofssonBOWiklundUArrhythmia: a pitfall in tests of cardiac autonomic function after liver transplantation for familial amyloidotic polyneuropathy; a long-term follow-up of Swedish patientsAmyloid20121928186
  • ObayashiKHörnstenRWiklundUBlood pressure overshoot after tilt reversal in patients with familial amyloidotic polyneuropathyHypertens Res201134113313820927118
  • ZhaoYHörnstenRLindqvistPWiklundUSuhrOBHeneinMYLeft ventricular dyssynchrony is associated with reduced heart rate variability in familial amyloidotic polyneuropathyInt J Cardiol2012155227327821056485
  • SuhrOBLindqvistPOlofssonBOWaldenströmABackmanCMyocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathyAmyloid200613315415917062381
  • RapezziCRivaLQuartaCCGender-related risk of myocardial involvement in systemic amyloidosisAmyloid2008151404818266120
  • BhandariAKNandaNCMyocardial texture characterization by two-dimensional echocardiographyAm J Cardiol19835158178256829442
  • FalkRHPlehnJFDeeringTSensitivity and specificity of the echocardiographic features of cardiac amyloidosisAm J Cardiol19875954184222949593
  • John SuttonMGStReichekNKastorJAGiulianiERComputerized M-mode echocardiographic analysis of left ventricular dysfunction in cardiac amyloidCirculation19826647907996214334
  • ChandrasekaranKAylwardPEFleagleSRFeasibility of identifying amyloid and hypertrophic cardiomyopathy with the use of computerized quantitative texture analysis of clinical echocardiographic dataJ Am Coll Cardiol19891348328402926037
  • ErikssonPBackmanCErikssonAErikssonSKarpKOlofssonBODifferentiation of cardiac amyloidosis and hypertrophic cardiomyopathy: a comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiographyActa Med Scand1987221139463565084
  • LindqvistPOlofssonBOBackmanCSuhrOWaldenströmAPulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathyEur J Echocardiogr200671223015869906
  • EngvallCHeneinMHolmgrenASuhrOBMörnerSLindqvistPCan myocardial strain differentiate hypertrophic from infiltrative etiology of a thickened septum?Echocardiography201128440841521323993
  • MigrinoRQHarmannLWoodsTBrightMTruranSHariPIntraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiographyCardiovasc Ultrasound200864018687125
  • RapezziCQuartaCCGuidalottiPLUsefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathyEur J Nucl Med Mol Imaging201138347047821069320
  • FalkRHLeeVWRubinowASkinnerMCohenASCardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosisAm J Cardiol1984548115011516093493
  • HongoMHirayamaJFujiiTEarly identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathyAm Heart J198711336546623030086
  • PeruginiERapezziCPivaTNon-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonanceHeart200692334334915939726
  • PalladiniGCampanaCKlersyCSerum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosisCirculation2003107192440244512719281
  • SuhrOBAnanIBackmanCDo troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?J Intern Med2008263329430118069997
  • PalladiniGBarassiAKlersyCThe combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosisBlood2010116183426343020644111
  • ErikssonAErikssonPOlofssonBOThornellLEThe cardiac atrioventricular conduction system in familial amyloidosis with polyneuropathy: a clinico-pathologic study of six cases from northern SwedenActa Pathol Microbiol Immunol Scand A19839153433496225293
  • ErikssonAErikssonPOlofssonBOThornellLEThe sinoatrial node in familial amyloidosis with polyneuropathy: a clinico-pathological study of nine cases from northern SwedenVirchows Arch A Pathol Anat Histopathol198440232392466322411
  • AndoYSuhrOBAutonomic dysfunction in familial amyloidotic polyneuropathy (FAP)Amyloid19985428830010036588
  • NiklassonUOlofssonBOBjerlePAutonomic neuropathy in familial amyloidotic polyneuropathy: a clinical study based on heart rate variabilityActa Neurol Scand19897931821872718736
  • BeckmanABjerlePOlofssonBElectrocardiographic findings in familial amyloidotic polyneuropathyAm J Noninvas Cardiol19926192196
  • De FreitasAFThe heart in Portuguese amyloidosisPostgrad Med J1986627286016053774701
  • De FreitasAFBarbedoAConduction disturbances in 190 patients with familial amyloidotic polyneuropathy (Andrade’s type)Adv Cardiol197821206209202146
  • SawayamaTKuriharaTArakiSNoninvasive cardiovascular findings in familial amyloid polyneuropathyBr Heart J1978401112881292718770
  • OkamotoSHörnstenRObayashiKWijayatungaPSuhrOBContinuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant)Liver Transpl201117212212821280184
  • HörnstenRWiklundUSuhrOBJensenSMVentricular late potentials in familial amyloidotic polyneuropathyJ Electrocardiol2006391576216387053
  • AnanIEl-SalhyMAndoYColonic enteric nervous system in patients with familial amyloidotic neuropathyActa Neuropathol1999981485410412800
  • AnanIEl-salhyMAndoYTerazakiHSuhrOBComparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathyActa Neuropathol2001102322723211585246
  • SuhrOBEriczonBGFrimanSLong-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type)Liver Transpl20028978779412200779
  • BerkJLDyckPJObiciLThe diflunisal trial: update on study drug tolerance and disease progressionAmyloid201118Suppl 119119222080762
  • LångKWikströmLDanielssonATashimaKSuhrOBOutcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathyScand J Gastroenterol200035998598911063162
  • LobatoLBeirãoISilvaMEnd-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factorsAmyloid2004111273715185496
  • LobatoLVenturaABeirãoIEnd-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantationTransplant Proc20033531116112012947881
  • NowakGSuhrOBWikströmLWilczekHEriczonBGThe long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patientsTranspl Int200518111111515612992
  • AndoEAndoYOkamuraRUchinoMAndoMNegiAOcular manifestations of familial amyloidotic polyneuropathy type I: long-term follow upBr J Ophthalmol19978142952989215058
  • AndoEAndoYHaraokaKOcular amyloid involvement after liver transplantation for polyneuropathyAnn Intern Med20011351093193211712896
  • SandgrenOKjellgrenDSuhrOBOcular manifestations in liver transplant recipients with familial amyloid polyneuropathyActa Ophthalmol200886552052418435819
  • SvendsenIHSteensgaard-HansenFNordvågBYA clinical, echocardiographic and genetic characterization of a Danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathyEur Heart J19981957827899717013
  • SuhrOBAndersenOAronssonTReport of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in SwedenAmyloid200916420821419922332
  • BuxbaumJNYeZReixachNTransthyretin protects Alzheimer’s mice from the behavioral and biochemical effects of Abeta toxicityProc Natl Acad Sci U S A200810572681268618272491
  • EpiskopouVMaedaSNishiguchiSDisruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormoneProc Natl Acad Sci U S A1993906237523798384721
  • BodinKEllmerichSKahanMCAntibodies to human serum amyloid P component eliminate visceral amyloid depositsNature20104687320939720962779
  • CoelhoTSuhrOBAdamsDPhase I safety, pharmacokinetic and pharmacodynamics results for ALN-TTR01, a novel RNAi therapeutic for the treatment of transthyretin amyloidosis (abstract)VIIIth International Symposium on Familial Amyloidotic PolyneuropathyKumamoto, Japan2011P62
  • MoniaBAckermanEGuoSBensonMDClinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy (abstract)VIIIth International Symposium on Familial Amyloidotic PolyneuropathyKumamoto, Japan2011P64
  • GillmoreJDTennentGAHutchinsonWLSustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosisBr J Haematol2010148576076720064157
  • CardosoIMerliniGSaraivaMJ4′-Iodo-4′-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disruptersFASEB J200317880380912724338
  • CardosoIMartinsDRibeiroTMerliniGSaraivaMJSynergy of combined doxycycline/TUDCA treatment in lowering transthyretin deposition and associated biomarkers: studies in FAP mouse modelsJ Transl Med201087420673327